Topoisomerase I is not the antigen targeted by the ADC. The drug binds HER2, is internalized, and releases the DXd payload, which inhibits Topoisomerase I to cause DNA damage and apoptosis (with bystander and ADCC effects). Killing is driven by HER2 targeting, not Top1 expression.